Lloyd A. Rowland, VP Legal & General Counsel at AMYLIN PHARMACEUTICALS INC (AMLN), sold 2,000 shares at $39.39 ($79K) on 2006-12-01, disclosed to the SEC on 2006-12-05.
Scheduled sale ($79k) by VP Legal & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CTMX | SELL | 2024-03-21 | $11K | — | Filing → |
| CTMX | SELL | 2023-12-22 | $6K | — | Filing → |
| CTMX | SELL | 2023-09-22 | $7K | — | Filing → |